# Quoin Pharmaceuticals, Ltd. — Form D

Quoin Pharmaceuticals, Ltd. of ASHBURN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-23. The offering totals $105.3M, of which $105.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-10-23
- Form: D
- Accession: 0001104659-25-101869
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $105.3M
- Amount sold: $105.3M
- Investors: 27
- Date of first sale: 2025-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561902

## Issuer

- Name: Quoin Pharmaceuticals, Ltd.
- CIK: 0001671502
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Phone: (703) 980-4182

## Officers, directors & promoters (29)

_Showing 25 of 29 people._

| Name | Role | Location |
| --- | --- | --- |
| Denise Bridget Carter | Director | Ashburn, VA |
| Joseph Bridget Cooper | Director | Ashburn, VA |
| James Bridget Culverwell | Director | Ashburn, VA |
| Dennis Bridget Langer | Director | Ashburn, VA |
| Natalie Bridget Leong | Director | Ashburn, VA |
| Michael Myers | Director | Ashburn, VA |
| Michael Bridget Sember | Director | Ashburn, VA |
| Denise Bridget Carter | Executive Officer | Ashburn, VA |
| Sally Bridget Lawlor | Executive Officer | Ashburn, VA |
| Michael Myers | Executive Officer | Ashburn, VA |
| Dennis Langer | Director | Naples, FL |
| James Culverwell | Director | Holytown, Motherwell, X0 |
| Gordon Dunn | Executive Officer | Tel Aviv, L3 |
| Michael Sember | Director | Tel Aviv, L3 |
| Denise Carter | Director | Tel Aviv, L3 |
| Denise Carter | Executive Officer | Tel Aviv, L3 |
| Natalie Leong | Director | Tel Aviv, L3 |
| Joseph Cooper | Director | Tel Aviv, L3 |
| Yuval Nuriel Berman | Director | Kfar Saba, L3 |
| Eyal Nuriel Leibovitz | Executive Officer | Kfar Saba, L3 |
| David Nuriel Braun | Director | Kfar Saba, L3 |
| Michael Nuriel Berelowitz | Director | Kfar Saba, L3 |
| Abraham Nuriel Nahmias | Director | Kfar Saba, L3 |
| Shai Nuriel Yarkoni | Director | Kfar Saba, L3 |
| Shai Nuriel Yarkoni | Executive Officer | Kfar Saba, L3 |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-08-31](https://search.stillhousedata.com/formd/0001458511-22-000001) | D | $194K | $194K |
| [2018-02-09](https://search.stillhousedata.com/formd/0001213900-18-001471) | D | $4.0M | $4.0M |
| [2017-09-19](https://search.stillhousedata.com/formd/0001213900-17-009834) | D | $4.3M | $4.3M |

## More

- [CIK 1671502 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1671502&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-25-101869.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.